cbdMD, Inc. (YCBD) Form 8-K — Nov 4, 2026
cbdMD, Inc. completed its acquisition of Twinlab's operating assets on October 30, 2026, adding the Twinlab, Reserveage, Metabolife and ResVitale brands via a Florida assignment-for-the-benefit-of-creditors sale approved by the Broward County court. Consideration included assumption of $1.75 million of senior secured debt owed to Akretive Holdings (a 9% two-year secured note), the issuance of 2,229,805 shares (19.9% of outstanding stock at $1.00 per share), 132,730 additional target percentage shares pending shareholder approval, and assumption of certain liabilities.
Key figures
- Debt Amount
- 1750000
- Interest Rate
- 9
- Maturity Date
- Two years from October 30, 2026 closing
- Offering Price
- 1
- Shares Offered
- 2229805
- Default interest rate
- 18
- Registration deadline months
- 9
- Shares percent of outstanding
- 19.9%
- Shareholder approval deadline days
- 270
- Additional target percentage shares
- 132730
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.